Author:
Lalla S.,Hothorn L. A.,Haag N.,Bader R.,Bauss F.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Reference23 articles.
1. Fleisch H. Bisphosphonates in bone disease. 3rd ed. New York: Parthenon Publishing, 1997.
2. Mühlbauer RC, Bauss F, Schenk R, et al. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. J Bone Miner Res 1991;6:1003–11.
3. Bauss F. Ibandronate in malignant bone diseases and osteoporosis preclinical results. Onkologie 1997;20:204–8.
4. Pecherstorfer M, Herrmann Z, Body J-J, et al. Randomized phase II trial comparing different doses of the bisphophonate ibandronate in the treatment of hypercalcemia of malignancy. J Clin Oncol 1996;14:268–76.
5. Yoneda T, Sasaki A, Dunstan C, et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 1997;99:2509–17.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献